News and Trends 21 Feb 2023
Hemab Therapeutics receives $135M to address bleeding and thrombotic disorders
Hemab Therapeutics, a clinical-stage biotechnology company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders, has announced…